Guggenheim Securities

Irving’s Caris Life Sciences Files for IPO, Backed by AI-Driven Precision Oncology Platform

by | May 28, 2025
With $1.86 billion raised since 2018 and recent product launches, the North Texas life science company founded in 2008 is preparing for a public debut on the Nasdaq Global Select Market, following a $168 million growth capital round in April.
MORE
Dallas’ Forte Biosciences Announces $53M Private Placement From Leading Healthcare Investors
by | Nov 21, 2024
Headquartered at Dallas' Pegasus Park, Forte Biosciences is developing a proprietary molecule with potentially broad autoimmune and autoimmune-related applications.
MORE